The Journal of Thoracic and Cardiovascular Surgery, Vol 87, 732-742, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
Pharmacologic antagonism of propranolol in dogs. III. Effects of dopamine-isoproterenol and glucagon on hemodynamics and myocardial oxygen consumption in ischemic hearts during chronic propranolol administration
J Wei, HM Spotnitz, WD Spotnitz, AI Benvenisty, GB Haasler, JR Malm and BF Hoffman
In 31 dogs chronically beta blocked with oral propranolol (12 to 14
mg/kg/day), glucagon (20 micrograms/kg) and combined dopamine (10
micrograms/kg/min) and isoproterenol (0.2 micrograms/kg/min) were given
intravenously and tested for hemodynamic efficacy. Dogs were divided into
four groups. Basal hemodynamics were obtained In Group I (n = 8) without
cardiopulmonary bypass. In Group II (n = 8), hemodynamics were studied
after 15 minutes of global ischemia during cardiopulmonary bypass. In Group
III (n = 8), hemodynamics were studied after regional ischemia produced by
ligation of the proximal left anterior descending coronary artery. In Group
IV (n = 7), myocardial oxygen consumption and left ventricular mechanics
were studied before and after 1 hour of cardiopulmonary bypass. Our results
indicate the following: (1) Dopamine-isoproterenol improves hemodynamics in
basal, post-global ischemic, and post-regional ischemic states. Glucagon
improves hemodynamics either insignificantly or to a lesser extent than
dopamine- isoproterenol. Furthermore, glucagon produces a larger increase
in heart rate, which is not desirable. (2) Both dopamine-isoproterenol and
glucagon increase myocardial oxygen consumption in comparison with control.